Abstract:Acid-sensing ion channels (ASICs) play a key role in the perception and response to extracellular acidification changes. These proton-gated cation channels are critical for neuronal functions, like learning and memory, fear, mechanosensation and internal adjustments like synaptic plasticity. Moreover, they play a key role in neuronal degeneration, ischemic neuronal injury, seizure termination, pain-sensing, etc. Functional ASICs are homo or heterotrimers formed with (ASIC1–ASIC3) homologous subunits. ASIC1a, a major ASIC isoform in the central nervous system (CNS), possesses an acidic pocket in the extracellular region, which is a key regulator of channel gating. Growing data suggest that ASIC1a channels are a potential therapeutic target for treating a variety of neurological disorders, including stroke, epilepsy and pain. Many studies were aimed at identifying allosteric modulators of ASIC channels. However, the regulation of ASICs remains poorly understood. Using all available crystal structures, which correspond to different functional states of ASIC1, and a molecular dynamics simulation (MD) protocol, we analyzed the process of channel inactivation. Then we applied a molecular docking procedure to predict the protein conformation suitable for the amiloride binding. To confirm the effect of its sole active blocker against the ASIC1 state transition route we studied the complex with another MD simulation run. Further experiments evaluated various compounds in the Enamine library that emerge with a detectable ASIC inhibitory activity. We performed a detailed analysis of the structural basis of ASIC1a inhibition by amiloride, using a combination of in silico approaches to visualize its interaction with the ion pore in the open state. An artificial activation (otherwise, expansion of the central pore) causes a complex modification of the channel structure, namely its transmembrane domain. The output protein conformations were used as a set of docking models, suitable for a high-throughput virtual screening of the Enamine chemical library. The outcome of the virtual screening was confirmed by electrophysiological assays with the best results shown for three hit compounds.

Structural insights into human acid-sensing ion channel 1a inhibition by snake toxin mambalgin1

Cryo-EM structure of the ASIC1a–mambalgin-1 complex reveals that the peptide toxin mambalgin-1 inhibits acid-sensing ion channels through an unusual allosteric effect

Revealing molecular determinants governing mambalgin-3 pharmacology at acid-sensing ion channel 1 variants

Disruption of Auto-Inhibition Underlies Conformational Signaling of ASIC1a to Induce Neuronal Necroptosis

A Bimodal Activation Mechanism Underlies Scorpion Toxin-Induced Pain.

Conformational plasticity of human acid-sensing ion channel 1a

The funnel-web spider venom derived single knot peptide Hc3a modulates acid-sensing ion channel 1a desensitisation

Identification of the modulatory Ca2+-binding sites of acid-sensing ion channel 1a

A Mechanism for Desensitization of All Three Functional Mammalian Acid Sensing Ion Channels

Acid-sensing ion channel 1a mediates acid-induced increases in intracellular calcium in rat articular chondrocytes

Identification of a unique Ca2+-binding site in rat acid-sensing ion channel 3

Highly Conserved Salt Bridge Stabilizes Rigid Signal Patch at Extracellular Loop Critical for Surface Expression of Acid-sensing Ion Channels

Mutagenesis of the Peptide Inhibitor of ASIC3 Channel Introduces Binding to Thumb Domain of ASIC1a but Reduces Analgesic Activity

Site-Specific Fluorescence Spectrum Detection And Characterization Of Hasic1a Channels Upon Toxin Mambalgin-1 Binding In Live Mammalian Cells

Molecular determinants of ASIC1 modulation by divalent cations

Inherent dynamics of the acid-sensing ion channel 1 correlates with the gating mechanism.

Voltage-Gated Sodium Channel Modulation by a New Spider Toxin Ssp1a Isolated From an Australian Theraphosid

A Nonproton Ligand Sensor in the Acid-Sensing Ion Channel

Structural basis for modulation of human Na V 1.3 by clinical drug and selective antagonist

Pi3-Kinase/Akt Pathway-Regulated Membrane Insertion Of Acid-Sensing Ion Channel 1a Underlies Bdnf-Induced Pain Hypersensitivity

4-(Azolyl)-Benzamidines as a Novel Chemotype for ASIC1a Inhibitors